In adults with acute severe ulcerative colitis on IV steroids, adding tofacitinib did not significantly reduce day-6 treatment failure vs placebo (24.2% vs 36.0%; RR 0.67, P=.33; 58 analysed, trial stopped early); adjusted RR 0.47. 90-day colectomy similar (12.1% vs 12.0%).
RCTn = 62
Arora et al. Dual therapy with tofacitinib and steroids for acute severe ulcerative colitis: a randomized double-blind placebo-controlled trial